{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201910155944/tandem-diabetes-care-up-10-to-work-with-abbott", "downloaded_at": "2019-10-15 14:57:39.739161+00:00", "title": "Tandem Diabetes Care Up 10%; To Work With Abbott", "language": "en", "text": "By Michael Dabaie\n\nTandem Diabetes Care Inc. (TNDM) shares were up 10% to $62.14 in Tuesday morning trading.\n\nAbbott Laboratories (ABT) and Tandem said Tuesday they would explore new integrated solutions for diabetes management.\n\nThe companies said they aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products.\n\nAbbott shares were up 2% to $81.58.\n\nWrite to Michael Dabaie at michael.dabaie@wsj.com\n\n(END) Dow Jones Newswires\n\nOctober 15, 2019 10:30 ET (14:30 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-10-15"}